IDXX Stock Recent News
IDXX LATEST HEADLINES
The Nasdaq Composite (^IXIC -0.82%) is one of the U.S. stock market's three major indexes, along with the S&P 500 and Dow Jones. It contains virtually every stock listed on the Nasdaq stock exchange and has been the best-performing index of the three over the past decade by a significant margin.
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 from 1:50 pm – 2:25 pm (ET). A live audio webcast of the presentation will be available through a li.
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.